March 7, 2025 – The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss. The approval marks the first and only ...
Get Instant Summarized Text (Gist) Research is advancing treatments for rare eye diseases, which are a leading cause of untreatable blindness in Europe. Seven rare ocular conditions affecting the ...
Encelto is small, semi-permeable capsule implanted in the eye that contains allogeneic retinal pigment epithelium cells ...
Rare eye diseases are the leading cause of untreatable blindness in Europe and affect people of all ages. The RESTORE VISION scientific team has identified seven rare ocular conditions that impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback